Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02300584 · ClinicalTrials.gov registry record · NA

Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program

A NA study of Depression and Dementia, sponsored by Emory University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT02300584 is a NA study of Depression and Dementia that has completed, run by Emory University. The registered enrollment target is 42 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02300584, a NA study of Depression and Dementia, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to refine and test the web-based delivery of a well-established in-person group program that provides information and education to informal caregivers (family and friends) of persons with Alzheimer's disease (or related illnesses).

Interventions

  • BEHAVIORAL Tele-Savvy
  • OTHER iPad

Study Locations (1)

Georgia

  • Emory Alzheimer's Disease Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2014-11
Est. Completion 2015-10
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02300584

The ClinicalTrials.gov registry entry for NCT02300584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Tele-Savvy is the first listed.

NCT02300584 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02300584 about?

NCT02300584 is a clinical study titled "Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program". The purpose of this study is to refine and test the web-based delivery of a well-established in-person group program that provides information and education to informal caregivers (family and friends) of persons with Alzheimer's disease (or related illnesses).

What is the current status of trial NCT02300584?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2014-11. Estimated completion is 2015-10.

What conditions does trial NCT02300584 study?

This clinical trial studies the following conditions: Depression, Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT02300584?

The interventions under investigation include: Tele-Savvy (BEHAVIORAL), iPad (OTHER).

Who is sponsoring clinical trial NCT02300584?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02300584 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.